x

Posted 11 January, 2024

INTERNATIONAL FLAVORS & FRAGRANCES INC appointed Mr. Fyrwald as new CEO

NYSE:IFF appointed new Chief Executive Officer Mr. Fyrwald in a 8-K filed on 11 January, 2024.


  In connection with Mr. Fyrwald's appointment as CEO, the Company entered into a letter agreement with Mr. Fyrwald on January 11, 2024 (the "Agreement"), a copy of which is attached hereto as Exhibit 10.2 and the terms and conditions of which are incorporated by reference herein.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of INTERNATIONAL FLAVORS & FRAGRANCES INC
Basic Materials/Resources • Chemicals
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Market Cap
$19.7B
View Company Details
Relevant filing section
Item 5.02 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


(b)

International Flavors & Fragrances Inc. ("IFF" or the "Company") announced on January 11, 2024 that Mr. Franklin K. Clyburn, Jr. who is currently Chief Executive Officer ("CEO") of the Company and a director of the Company's Board of Directors (the "Board"), will cease to serve as CEO and a director of the Board, effective February 6, 2024. Mr. Clyburn is expected to remain employed with the Company in a transitional role until March 31, 2024, and subsequently is expected to provide advisory services in a consulting role until December 31, 2024. Mr. Clyburn's departure is a qualifying event for purposes of IFF's Amended and Restated Executive Severance Policy (the "Executive Severance Policy"). Per the terms and conditions of the Executive Severance Policy, Mr. Clyburn is entitled to termination benefits consisting of (i) a cash separation payment equal to two times the sum of (A) Mr. Clyburn's annual base salary plus (B) Mr. Clyburn's target annual bonus opportunity for fiscal year 2024, prorated based upon the number of active days of employment (ii) 24 months of benefits continuation and (iii) pro-rata vesting of his outstanding restricted share unit, stock appreciation rights and performance share unit awards (with performance share units remaining subject to achievement of actual performance at the end of the applicable performance period). In addition, per the terms and conditions of Mr. Clyburn's letter agreement with the Company, dated January 18, 2022, the sign-on equity awards granted to Mr. Clyburn on March 1, 2022 will continue to vest in full (with performance share units remaining subject to achievement of actual performance at the end of the applicable performance period). As consideration for his consulting services from April 1, 2024 through December 31, 2024, Mr. Clyburn will receive a total consulting fee of $1,000,000, paid in equal monthly installments. In connection with the foregoing, the Company entered into a separation and transition agreement with Mr. Clyburn on January 11, 2024 (the "Clyburn Agreement"), a copy of which is attached hereto as Exhibit 10.1 and the terms and conditions of which are incorporated by reference herein.

(c)

On January 11, 2024, the Company announced that, effective February 6, 2024, J. Erik Fyrwald has been appointed CEO of the Company and has been appointed to serve as a director of the Board. He will also be named to the Board's Innovation Committee and Transaction Committee. Mr. Fyrwald, 64, previously served as the CEO and executive director of the board of directors of the Syngenta Group, a leading global agriculture company, from June 2016 to December 2023, and he served as the chairman of the Syngenta Foundation from 2018 to December 2023. Mr. Fyrwald is currently a member of the board of directors of the Syngenta Group and Eli Lilly and Company.

Mr. Fyrwald does not have any family relationships with any director or executive officer of the Company, and there are no arrangements or understandings with any persons pursuant to which Mr. Fyrwald has been appointed to his position. In addition, there have been no transactions directly or indirectly involving Mr. Fyrwald that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended.

In connection with Mr. Fyrwald's appointment as CEO, the Company entered into a letter agreement with Mr. Fyrwald on January 11, 2024 (the "Agreement"), a copy of which is attached hereto as Exhibit 10.2 and the terms and conditions of which are incorporated by reference herein.

Pursuant to the Agreement, Mr. Fyrwald will be entitled to the following compensation: (1) annual base salary of $1,000,000; (2) a target annual bonus opportunity of 200% of Mr. Fyrwald's annual base salary; (3) participation in the Company's Long-Term Incentive Plan (the "LTIP") with a target award opportunity for the annual 2024 grant cycle of $10,00,000 (60% in performance share units and 40% in restricted stock units) (the "Target LTI"); and (4) as an inducement to have Mr. Fyrwald accept the offer from the Company, one-time equity awards consisting of a target award of 68,750 performance share units and 56,250 restricted stock units (the "Inducement Awards"). It is expected that the Inducement Awards will be granted on March 1, 2024 as "employment inducement awards" under the NYSE Listed Company Manual Rule 303A.08.


In the event Mr. Fyrwald's employment is terminated by the Company without "cause" or by Mr. Fyrwald for "good reason", Mr. Fyrwald will be entitled to the benefits provided in the Executive Severance Policy and to the continued vesting of the restricted stock unit portion of the Inducement Award in full on the existing vesting schedule. In addition, under the Security Agreement which is attached as Exhibit B to his Agreement and the terms and conditions of which are incorporated by reference herein, Mr. Fyrwald is subject to non-competition covenants while employed by the Company and for one year following a termination of employment, non-solicitation covenants while employed by the Company and for two years following a termination of employment, and ongoing confidentiality, cooperation and non-disparagement covenants. Mr. Fyrwald will not receive any additional compensation for his service on the Board.